Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
2.815
+0.060 (2.18%)
Nov 20, 2024, 4:00 PM EST - Market closed
Galectin Therapeutics Employees
Galectin Therapeutics had 14 employees as of December 31, 2023. The number of employees increased by 2 or 16.67% compared to the previous year.
Employees
14
Change (1Y)
2
Growth (1Y)
16.67%
Revenue / Employee
n/a
Profits / Employee
-$3,230,714
Market Cap
176.67M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accuray | 987 |
Senseonics Holdings | 132 |
Stereotaxis | 122 |
MediWound | 100 |
Lineage Cell Therapeutics | 75 |
Verastem | 73 |
DiaMedica Therapeutics | 19 |
Actuate Therapeutics | 5 |
GALT News
- 3 days ago - Galectin Therapeutics Presents Three Abstracts at the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting - GlobeNewsWire
- 7 days ago - Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Galectin Therapeutics Announces Acceptance of Three Abstracts for the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting - GlobeNewsWire
- 2 months ago - Galectin Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2024 and Provides Business Update - GlobeNewsWire
- 4 months ago - Galectin Therapeutics Appoints Khurram Jamil, M.D. to Chief Medical Officer - GlobeNewsWire
- 6 months ago - Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2024 Congress - GlobeNewsWire
- 6 months ago - Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2024 and Provides Business Update - GlobeNewsWire